Saturday, April 29, 2017
- 5:30pm-7:30pm
-
Down-Regulation of Nuclear HMGB1 by Small Interfering RNA Protects Against Liver Ischemia-Reperfusion Injury.
- 5:30pm-7:30pm
-
DSA Presence Does Not Affect Renal Histology and Clinical Outcome in Chronic Active Antibody Mediated Rejection.
- 5:30pm-7:30pm
-
Early Antibody-Mediated Rejection C4d Status Remains a Marker of Prognosis in HLA-Incompatible Kidney Transplantation.
- 5:30pm-7:30pm
-
Effect of Bone Marrow Derived Mesenchymal Stem Cells on Renal Ischemia-Reperfusion Injury in Rabbit.
- 5:30pm-7:30pm
-
Effect of Embolization History and Tumor Treatment Response on Plasma TGFβ in HCC Patients Listed for Liver Transplantation.
- 5:30pm-7:30pm
-
Effect of Epigenetic Modifications in Ischemia-Reperfusion-Injury Post Liver Transplantation: An Integrative Approach.
- 5:30pm-7:30pm
-
Effect of Induction Therapy in ABO Incompatible Living-Donor Kidney Transplantation: A Single Center Experience.
- 5:30pm-7:30pm
-
Effect of Influenza Vaccination in the Severity of Illness in Hospitalized Transplant Recipients with Laboratory-Confirmed Influenza.
Poster Session A: Viral Conundrums • Hall D1
- 5:30pm-7:30pm
-
Eight Years of Low-Dose Valganciclovir; Evaluating the Incidence and Risk Factors of CMV in Kidney Transplant Recipients.
Poster Session A: Viral Conundrums • Hall D1
- «Previous Page
- 1
- …
- 7
- 8
- 9
- 10
- 11
- …
- 32
- Next Page»